Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum β-lactamase production in Enterobacter spp.

被引：12

作者：

Schwaber, MJ

Navon-Venezia, S

Chmelnitsky, I

Leavitt, A

Schwartz, D

Carmeli, Y

机构：

[1] Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-64239 Tel Aviv, Israel

[2] Tel Aviv Sourasky Med Ctr, Clin Microbiol Lab, IL-64239 Tel Aviv, Israel

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2006年 / 44卷 / 01期

关键词：

D O I：

10.1128/JCM.44.1.241-243.2006

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Forty clinical isolates of Enterobacter spp. were identified as extended-spectrum P-lactamase (ESBL) producers by disk diffusion. The VITEK 2 Advanced Expert System (AES) identified the ESBL phenotype in only 25 isolates (62.5%), and erroneously reported cephalosporin susceptibility in 11 isolates (28%). Refinements in the AES are required in order to improve ESBL detection in Enterobacter.

引用

页码：241 / 243

页数：3

共 17 条

[1] [Anonymous], [No title captured]
[2] Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant β-lactamases
Cantón, R
Pérez-Vázquez, M
Oliver, A
Coque, TM
Loza, E
Ponz, F
Baquero, F
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (1-2) : 65 - 70
[3] Detection and characterization of extended-spectrum β-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002
Ho, PL
Shek, RHL
Chow, KH
Duan, RS
Mak, GC
Lai, EL
Yam, WC
Tsang, KW
Lai, WM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (03) : 326 - 332
[4] Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp.
Leverstein-van Hall, MA
Fluit, AC
Paauw, A
Box, ATA
Brisse, S
Verhoef, J
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (10) : 3703 - 3711
[5] Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests
Linscott, AJ
Brown, WJ
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (03) : 1081 - 1085
[6] Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests
Livermore, DM
Struelens, M
Amorim, J
Baquero, F
Bille, J
Canton, R
Henning, S
Gatermann, S
Marchese, A
Mittermayer, H
Nonhoff, C
Oakton, KJ
Praplan, F
Ramos, H
Schito, GC
Van Eldere, J
Verhaegen, J
Verhoef, J
Visser, MR
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) : 289 - 300
[7] Detection of extended spectrum β-lactamases in the routine clinical microbiology laboratory
Midolo, PD
Matthews, D
Fernandez, CD
Kerr, IG
[J]. PATHOLOGY, 2002, 34 (04) : 362 - 364
[8] In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide:: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)
Paterson, DL
Rossi, F
Baquero, F
Hsueh, PR
Woods, GL
Satishchandran, V
Snyder, TA
Harvey, CM
Teppler, H
DiNubile, MJ
Chow, JW
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) : 965 - 973
[9] Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test
Sanders, CC
Barry, AL
Washington, JA
Shubert, C
Moland, ES
Traczewski, MM
Knapp, C
Mulder, R
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) : 2997 - 3001
[10] Ability of the VITEK 2 advanced expert system to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa
Sanders, CC
Peyret, M
Moland, ES
Shubert, C
Thomson, KS
Boeufgras, JM
Sanders, WE
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 570 - 574

← 1 2 →